This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
8/2/2022
The conference will begin shortly. To raise your hand during Q&A, you can dial star 1 1.
Good day and thank you for standing by. Welcome to the TALIS Biomedicals Business Update conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 11 on your telephone. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Emily Fossett, SVP, Corporate Communications and Investor Relations.
Good afternoon and thank you. Joining me today are Rob Kelly, our Chief Executive Officer, and Roger Moody, our Chief Financial Officer. Earlier today, the company released a business update in financial results for the quarter ended June 30th, 2022. A copy of that press release can be accessed on the investors page of our website at talusbio.com. Before we get started, I would like to remind you that management will make remarks during this call that are forward-looking statements within the meaning of the federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated. Additional information regarding these risks and uncertainties appears in the section entitled Forward Looking Statements in the Press Release, TALIS Issues Today. For a more complete list and description, please see the company's filings with the SEC, including the risk factors section of the company's 10Q, filed on August 2, 2022, and in its other filings. Except as required by law, TALIS disclaims any intention or obligation to update or revise any financial projections or forward-looking statements, whether because of new information, future events, or otherwise. This conference call contains time-sensitive information and is accurate only as of the live broadcast on August 2nd, 2022. With that, I'd like to turn the call over to Rob.
You're reading a preview of the TLIS Q2 2022 earnings call.
Free account.
